186 related articles for article (PubMed ID: 22971346)
1. Differential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasis.
Heinzle C; Gsur A; Hunjadi M; Erdem Z; Gauglhofer C; Stättner S; Karner J; Klimpfinger M; Wrba F; Reti A; Hegedus B; Baierl A; Grasl-Kraupp B; Holzmann K; Grusch M; Berger W; Marian B
Cancer Res; 2012 Nov; 72(22):5767-77. PubMed ID: 22971346
[TBL] [Abstract][Full Text] [Related]
2. Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
Bange J; Prechtl D; Cheburkin Y; Specht K; Harbeck N; Schmitt M; Knyazeva T; Müller S; Gärtner S; Sures I; Wang H; Imyanitov E; Häring HU; Knayzev P; Iacobelli S; Höfler H; Ullrich A
Cancer Res; 2002 Feb; 62(3):840-7. PubMed ID: 11830541
[TBL] [Abstract][Full Text] [Related]
3. ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma.
Choi KY; Rho YS; Kwon KH; Chung EJ; Kim JH; Park IS; Lee DJ
Cancer Biomark; 2012-2013; 12(3):115-24. PubMed ID: 23481570
[TBL] [Abstract][Full Text] [Related]
4. The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.
da Costa Andrade VC; Parise O; Hors CP; de Melo Martins PC; Silva AP; Garicochea B
Exp Mol Pathol; 2007 Feb; 82(1):53-7. PubMed ID: 17084840
[TBL] [Abstract][Full Text] [Related]
5. Role of fibroblast growth factor 4 in the growth and metastasis of colorectal cancer.
Ye Y; Jiang D; Li J; Han C; Wang X; Wang F; Li J
Int J Oncol; 2020 Jun; 56(6):1565-1573. PubMed ID: 32236572
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism of FGFR4 Gly388Arg does not confer an increased risk to breast cancer development.
Naidu R; Har YC; Taib NA
Oncol Res; 2009; 18(2-3):65-71. PubMed ID: 20066896
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancer.
Zhu X; Zheng L; Asa SL; Ezzat S
Am J Pathol; 2010 Dec; 177(6):2860-9. PubMed ID: 21037081
[TBL] [Abstract][Full Text] [Related]
8.
Cho SH; Hong CS; Kim HN; Shin MH; Kim KR; Shim HJ; Hwang JE; Bae WK; Chung IJ
Cancer Res Treat; 2017 Jul; 49(3):766-777. PubMed ID: 27857023
[TBL] [Abstract][Full Text] [Related]
9. FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC.
Chen X; Chen J; Feng W; Huang W; Wang G; Sun M; Luo X; Wang Y; Nie Y; Fan D; Wu K; Xia L
Theranostics; 2023; 13(4):1401-1418. PubMed ID: 36923538
[No Abstract] [Full Text] [Related]
10. FGFR4 role in epithelial-mesenchymal transition and its therapeutic value in colorectal cancer.
Peláez-García A; Barderas R; Torres S; Hernández-Varas P; Teixidó J; Bonilla F; de Herreros AG; Casal JI
PLoS One; 2013; 8(5):e63695. PubMed ID: 23696849
[TBL] [Abstract][Full Text] [Related]
11. Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression.
Liu J; Zhang Z; Li X; Chen J; Wang G; Tian Z; Qian M; Chen Z; Guo H; Tang G; Huang W; Tian D; Wang D; Nie Y; Fan D; Wu K; Xia L
Oncogene; 2018 Oct; 37(41):5477-5491. PubMed ID: 29884889
[TBL] [Abstract][Full Text] [Related]
12. The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy.
Serra S; Zheng L; Hassan M; Phan AT; Woodhouse LJ; Yao JC; Ezzat S; Asa SL
Cancer Res; 2012 Nov; 72(22):5683-91. PubMed ID: 22986737
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of FGFR4 in cancer development and sensitivity to cisplatin and radiation in head and neck cancer.
Ansell A; Farnebo L; Grénman R; Roberg K; Thunell LK
Oral Oncol; 2009 Jan; 45(1):23-9. PubMed ID: 18487077
[TBL] [Abstract][Full Text] [Related]
14. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N
J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847
[TBL] [Abstract][Full Text] [Related]
15. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA
Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a single nucleotide polymorphism in codon 388 of the FGFR4 gene in malignant gliomas.
Mawrin C; Kirches E; Diete S; Wiedemann FR; Schneider T; Firsching R; Kropf S; Bogerts B; Vorwerk CK; Krüger S; Dietzmann K
Cancer Lett; 2006 Aug; 239(2):239-45. PubMed ID: 16198476
[TBL] [Abstract][Full Text] [Related]
17. Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma.
Tsay MD; Hsieh MJ; Lee CY; Wang SS; Chen CS; Hung SC; Lin CY; Yang SF
Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31878098
[TBL] [Abstract][Full Text] [Related]
18. FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7.
Bai YP; Shang K; Chen H; Ding F; Wang Z; Liang C; Xu Y; Sun MH; Li YY
Cancer Sci; 2015 Oct; 106(10):1278-87. PubMed ID: 26183471
[TBL] [Abstract][Full Text] [Related]
19. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
[TBL] [Abstract][Full Text] [Related]
20. Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.
Jiang Y; Sun S; Wei W; Ren Y; Liu J; Pang D
Oncotarget; 2015 Oct; 6(32):34023-9. PubMed ID: 26431494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
